secwatch.observer — SEC 8-K summary
======================================

Issuer:     CervoMed Inc. (CRVO)
CIK:        0001053691
Form:       8-K
Filed at:   2024-10-03T23:59:59+00:00
Accession:  0001437749-24-030613
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 1.02
LLM model:  deepseek-v4-flash:cloud@v2

CervoMed terminates $20M ATM equity facility with BTIG; no shares sold
----------------------------------------------------------------------

- Terminated At-The-Market Sales Agreement with BTIG, effective October 11, 2024.
- No shares were ever issued under the $20M facility; no termination penalties apply.
- Company notified BTIG on October 1, 2024 of the termination.
- Originally entered into July 22, 2022; no proceeds or dilution occurred.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1053691/000143774924030613/0001437749-24-030613-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1053691/000143774924030613/crvo20241002_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-030613

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer